FcRn inhibitors: a novel option for the treatment of myasthenia gravis
Li-Na Zhu
Hai-Man Hou
Sai Wang
Shuang Zhang
Ge-Ge Wang
Zi-Yan Guo
Jun Wu
Keywords：batoclimabclinical trialefgartigimodFcRnFcRn inhibitorsimmunoglobulin G (IgG)myasthenia gravisnipocalimabrozanolixizumab
Publication Date：2023-08-28
Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)
Pages：8( 1637-1644 )